TACR1 and benign neoplasm: The pre-malignant and malignant groups were also combined, obtaining a high expression for SP/NK-1R, approximately one half of the cases (PP = 50.93%, 95%CI = 32.13–69.61), also showing significant differences with the benign tumors group (p = 0.002).